07/17/2025
4:03 PM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/03/2025
3:31 PM | Brainstorm Cell Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/25/2025
3:31 PM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/25/2025
3:39 PM | Brainstorm Cell Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
05/16/2025
6:15 AM | Brainstorm Cell Therapeutics (Filer)
| Form ARS | |
05/16/2025
6:00 AM | Brainstorm Cell Therapeutics (Filer)
| Form DEF 14A | |
05/16/2025
6:05 AM | Brainstorm Cell Therapeutics (Filer)
| Form DEFA14A | |
05/15/2025
2:07 PM | ARMISTICE CAPITAL, LLC (Filed by)
Brainstorm Cell Therapeutics (Subject)
| Form SCHEDULE 13G | |
05/06/2025
3:30 PM | Brainstorm Cell Therapeutics (Filer)
| Form PRE 14A | |
03/31/2025
6:30 AM | Brainstorm Cell Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/31/2025
6:10 AM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for BCLI and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Brainstorm Cell Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
03/31/2025
5:30 AM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/27/2025
7:00 AM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
4:25 PM | ARMISTICE CAPITAL, LLC (Filed by)
Brainstorm Cell Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
01/21/2025
4:25 PM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/15/2025
3:22 PM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/07/2025
3:10 PM | Brainstorm Cell Therapeutics (Issuer)
Dagher Ibrahim B. (Reporting)
| Form 3/A | |
01/07/2025
3:11 PM | Brainstorm Cell Therapeutics (Issuer)
Dagher Ibrahim B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2025
4:30 PM | ARBEL IRIT (Reporting)
Brainstorm Cell Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2025
4:31 PM | Bairu Menghisteab (Reporting)
Brainstorm Cell Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2025
4:31 PM | Brainstorm Cell Therapeutics (Issuer)
HARTOUNIAN HARTOUN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2025
4:32 PM | Brainstorm Cell Therapeutics (Issuer)
Lindborg Stacy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2025
4:32 PM | Brainstorm Cell Therapeutics (Issuer)
Naor Nir (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2025
4:33 PM | Brainstorm Cell Therapeutics (Issuer)
Patlis Alla (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2025
4:34 PM | Brainstorm Cell Therapeutics (Issuer)
Yablonka Uri (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2025
4:34 PM | Brainstorm Cell Therapeutics (Issuer)
Polverino Anthony J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2025
4:36 PM | Brainstorm Cell Therapeutics (Issuer)
FRENKEL JACOB A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2025
4:36 PM | Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
2:24 PM | ARMISTICE CAPITAL, LLC (Filed by)
Brainstorm Cell Therapeutics (Subject)
| Form SC 13G | |
11/13/2024
6:55 AM | Brainstorm Cell Therapeutics (Subject)
Ruck Matthew J (Filed by)
| Form SC 13G | |
10/30/2024
7:41 AM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/02/2024
7:00 AM | Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2024
7:00 AM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/29/2024
11:15 PM | Brainstorm Cell Therapeutics (Filer)
| Form EFFECT | |
09/26/2024
3:30 PM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/24/2024
3:30 PM | Brainstorm Cell Therapeutics (Filer)
| Form S-3/A | |
09/17/2024
2:32 PM | Brainstorm Cell Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
09/16/2024
3:36 PM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/08/2024
11:15 PM | Brainstorm Cell Therapeutics (Filer)
| Form EFFECT | |
08/28/2024
4:01 PM | Brainstorm Cell Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
08/16/2024
6:00 AM | Brainstorm Cell Therapeutics (Filer)
| Form DEF 14A | |
Critical AI announcement set to ignite AI 2.0 (Ad) Markets are jittery. Rallies fade. Sectors rotate overnight. And the true impact of new tariffs and policy shifts hasn’t even hit the data yet.
That’s why smart traders are turning to a strategy built for exactly this kind of market—fast, simple, and designed to react to real price action, not predictions. Click here to watch how it works—and why it could give smaller traders an edge before the next big m |
08/16/2024
6:03 AM | Brainstorm Cell Therapeutics (Filer)
| Form ARS | |
08/14/2024
7:01 AM | Brainstorm Cell Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/14/2024
6:15 AM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
